Profile picture

Doctor Klaus Witte

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)
Membership: FESC Member EAPC Member EHRA Member HFA Member
Follow
Biography
Klaus Witte is a Cardiologist at the Leeds Institute of Cardiovascular & Metabolic Medicine (GB). His group is driven by patient-orientated questions and a common desire to improve efficacy by personalising the use of new and old therapies in CHF. He has long questioned standard teaching around heart rate and exercise capacity in CHF (JACC 2016). His group has described a reliable way to map the force-frequency relationship in CHF and that by using this approach can improve exercise capacity in people with CHF and pacemakers (JACC-HF 2018, Circulation 2020). Future challenges he looks forward to facing include the growing issue of health economics across Europe, how pathways of care need to adapt, and how to explain the ever more complex molecular basis of clinical syndromes to colleagues, patients and carers. He is most proud of the diversity of the teams he works with which include researchers from all aspects of healthcare.
Logo ESC

Contributor content

Implications of atrial fibrillation in heart failure: vicious twins
Session
Implications of atrial fibrillation in heart failure: vicious twins
14 April 2026
Arrhythmias in cardiac sarcoidosis
Session
Arrhythmias in cardiac sarcoidosis
14 April 2026
Heart failure and multi-organ impact: treatment approaches
Session
Heart failure and multi-organ impact: treatment approaches
31 August 2025
Assessing risk in heart failure with novel biomarkers
Session
Assessing risk in heart failure with novel biomarkers
30 August 2025
Late-breaking clinical trials in chronic heart failure
Session
Late-breaking clinical trials in chronic heart failure
18 May 2025
Case-based discussion: device therapy in heart failure
Session
Case-based discussion: device therapy in heart failure
17 May 2025
Session VI: Comorbidities, Valvular Heart Diseases and cardiomyopathies
Session
Session VI: Comorbidities, Valvular Heart Diseases and cardiomyopathies
16 October 2024
Meet the experts: device therapy in heart failure
Session
Meet the experts: device therapy in heart failure
22 May 2023
Case based discussion: device therapy in heart failure
Session
Case based discussion: device therapy in heart failure
22 May 2023
Valvular heart disease 3
Session
Valvular heart disease 3
22 May 2023

ESC 365 is supported by